Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by ronzon Feb 24, 2009 12:08pm
441 Views
Post# 15799693

Warrant incentive program not working as planned??

Warrant incentive program not working as planned??With the price still down near the warrant price from the incentive plan, Nuvo will not very likely benefit from the program since the price stayed down from the news of their FDA submission  last week. I like many others thought that it should be over 20-cents by now but the selling is killing any oppertunity that the company has to capitalize on the warrant incentive program. Unless they announce an agreement with a partner before the program expires, I don't think that much else will drive this up to where the warrant holders will want to buy, and the FDA approval is still a ways away!
Bullboard Posts